DSM Biologics and Upfront to Develop a Fully Disposable Chromatography System Optimized for High Yield Cell Line Production
DSM Biologics (Heerlen, the Netherlands), and Upfront Chromatography A/S (Copenhagen, Denmark) have announced a collaboration to optimize Upfront’s new, fully disposable chromatography system for use with DSM's proprietary manufacturing technology.
DSM Biologics (Heerlen, the Netherlands), and Upfront Chromatography A/S (Copenhagen, Denmark) have announced a collaboration to optimize Upfront’s new, fully disposable chromatography system for use with DSM's proprietary manufacturing technology. The fully integrated disposable chromatography system is expected to be available for commercial use by the summer of 2008.
The combination of Upfront’s disposable chromatography system and DSM’s proprietary manufacturing technology is designed to deliver a flexible, easy-to-use, high capacity bioprocessing platform that can be scaled from 0.1 to 100 L for commercial manufacture and recovery of a range of biopharmaceuticals, including monoclonal antibodies.
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.
